Shanghai Pharmaceuticals Holding Co., Ltd

$7.60+0.00%(+$0.00)
TickerSpark Score
63/100
Mixed
93
Valuation
50
Profitability
70
Growth
72
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHPMY research report →

52-Week Range52% of range
Low $6.83
Current $7.60
High $8.32

Companywww.sphchina.com

Shanghai Pharmaceuticals Holding Co. , Ltd. , an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China.

CEO
Qiuhua Yang
IPO
2014
Employees
49,402
HQ
Shanghai, CN

Price Chart

+11.27% · this period
$8.30$7.57$6.83May 20Nov 18May 20

Valuation

Market Cap
$5.64B
P/E
10.63
P/S
0.21
P/B
0.80
EV/EBITDA
8.91
Div Yield
2.46%

Profitability

Gross Margin
10.83%
Op Margin
3.53%
Net Margin
2.02%
ROE
7.64%
ROIC
4.62%

Growth & Income

Revenue
$283.58B · 3.03%
Net Income
$5.72B · 25.74%
EPS
$7.70 · 25.20%
Op Income
$9.94B
FCF YoY
11.73%

Performance & Tape

52W High
$8.32
52W Low
$6.83
50D MA
$7.60
200D MA
$7.91
Beta
0.25
Avg Volume
6

Get TickerSpark's AI analysis on SHPMY

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our SHPMY Coverage

We haven't published any research on SHPMY yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate SHPMY Report →

Similar Companies